SCHEMBL6893216

SCHEMBL6893216

Cc1ncnc(Cl)c1-c1cccnc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 10/20 0.50
CYP3A4 P08684 3/20 0.47
CYP1A2 P05177 2/20 0.45
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 2/20 0.43
HTT P42858 2/20 0.43
HSD17B10 Q99714 2/20 0.43
RXFP1 Q9HBX9 1/20 0.42
NPY5R Q15761 2/20 0.41
KIF11 P52732 1/20 0.41
TYMP P19971 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
LMNA P02545 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
MAPK1 P28482 1/20 0.40
HIF1A Q16665 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16461405 0.80 LMNA (0.47) CYP1A2ALDH1A1KDM4EHTTHSD17B10
SCHEMBL6894053 0.75 PIK3CD (0.50) CYP1A2
SCHEMBL12138044 0.74 RXFP1 (0.52) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL29912818 0.74 CYP2A6 (0.53) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL4484319 0.74 CYP2A6 (0.53) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL16056691 0.71 KDM4E (0.48) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL30977173 0.71 CYP11B1 (0.50) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL22233764 0.71 CYP11B1 (0.50) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL27879628 0.71 RXFP1 (0.46) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL11965538 0.71 CYP2A6 (0.78) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028952-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-02-02 US disclosed
US-20120028958-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-02-02 US disclosed
WO-2011092198-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028958-A1 5-ALKYNYL-PYRIMIDINES MKI67, CCNA1, CCNT1 CYP2A6 1066/4885CYP3A4 1080/4885CYP1A2 407/4885
US-20120028952-A1 5-ALKYNYL-PYRIMIDINES MKI67, CCNA1, CCNT1 CYP2A6 836/4885CYP3A4 1251/4885CYP1A2 325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.